SLC27A4
protein-codingsolute carrier family 27 member 4, the group of Acyl-CoA synthetase family|Solute carrier family 27
Gene summary
This gene encodes a member of a family of fatty acid transport proteins, which are involved in translocation of long-chain fatty acids cross the plasma membrane. This protein is expressed at high levels on the apical side of mature enterocytes in the small intestine, and appears to be the principal fatty acid transporter in enterocytes. Clinical studies suggest this gene as a candidate gene for the insulin resistance syndrome. Mutations in this gene have been associated with ichthyosis prematurity syndrome. [provided by RefSeq, Apr 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~20.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012089
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012089
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012089
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012089
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0012089
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Obstetric
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The obstetric manifestations involve maternal mid-trimester complications of pregnancy leading to prematurity
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC27A4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005094.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 201 | 3 | 207 | ||
| missense | 4 | 10 | 134 | 8 | 156 | |
| nonsense | 5 | 7 | 12 | |||
| start loss | 1 | 1 | ||||
| frameshift | 10 | 3 | 1 | 14 | ||
| splice donor/acceptor (+/-2bp) | 3 | 13 | 4 | 20 | ||
| Total | 23 | 33 | 142 | 209 | 3 | 410 |
Highest pathogenic variant AF is 0.00015179264
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005085.2 | 12 | MANE Select | |
| Ensembl | ENSP00000300456.3 | 12 | MANE Select | |
| Ensembl | ENSP00000361961.1 | 6 | Standard | |
| Ensembl | ENSP00000361961.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Insulin resistance - Homo sapiens (human)
- Fat digestion and absorption - Homo sapiens (human)
- PPAR signaling pathway - Homo sapiens (human)
- PPAR signaling pathway
- Transport of fatty acids
Biological Process
- medium-chain fatty acid transport
- long-chain fatty acid metabolic process
- lipid metabolic process
- response to nutrient
- fatty acid transport
Molecular Function
- nucleotide binding
- long-chain fatty acid-CoA ligase activity
- long-chain fatty acid transporter activity
- fatty acid transmembrane transporter activity
- very long-chain fatty acid-CoA ligase activity
Cellular Component
- endoplasmic reticulum membrane
- plasma membrane
- microvillus
- membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000300456
- Coding exons
- 12
- Length
- 20825
- Individuals with no LoFs
- 125670
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 78
- Defined
- 125748
- p
- 0.000310
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.232 | 400 | 413 | 0.968 | 0.0000299 | 4142 |
| Missense (PolyPhen) | 158 | 176.13 | 0.89707 | 1760 | ||
| Synonymous | -0.790 | 190 | 177 | 1.08 | 0.0000124 | 1347 |
| Loss of Function | 2.76 | 12 | 27.7 | 0.433 | 0.00000138 | 316 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00014 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00063 | 0.00060 | rare |
| European (Non-Finnish) | 0.00045 | 0.00044 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in translocation of long-chain fatty acids (LFCA) across the plasma membrane. Appears to be the principal fatty acid transporter in small intestinal enterocytes. Plays a role in the formation of the epidermal barrier. Required for fat absorption in early embryogenesis. Has acyl-CoA ligase activity for long-chain and very-long-chain fatty acids (VLCFAs). Indirectly inhibits RPE65 via substrate competition and via production of VLCFA derivatives like lignoceroyl-CoA. Prevents light-induced degeneration of rods and cones (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.187
Intolerance Scores
- LoFtool
- 0.636
- RVIS EVS
- -1.08
- RVIS percentile EVS
- 7.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.976
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |